Involvement of the hospital pharmacist in securing the chimeric antigen receptor (CAR)-T cell circuit
This study enabled us to identify the potential risks of the CAR-T cell circuit at the Jules Bordet Institute. The hospital pharmacy was involved in resolving 54% (62/114) of the failure modes. This confirms the hospital pharmacist's central role in ensuring the safety of the CAR-T cell circuit.
Authors
- Angélic Bryla (ORCID: https://orcid.org/0000-0002-5287-5605)
- Audrey Vervacke
- Sophie Lorent
- L Alexandre
- Garance Scolas
Institutions
- Institut Jules Bordet (BE)
- Erasmus Hospital (BE)
Publication Details
- Journal
- European Journal of Hospital Pharmacy
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1136/ejhpharm-2024-004454
- Citations
- 1
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 1.05